With the analysis among 14,178 patents, we discovered top 442 key players by total patent application. Immatics Biotechnologies GmbH, Iovance Biotherapeutics, Inc., Novartis AG are dominant in this area. They take 5.05% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 268
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 232
Basel-Stadt, Switzerland
Patent: 216
New York, United States
Patent: 163
California, United States
Patent: 150
Yeda Research & Development Co. Ltd.
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 124
Massachusetts, United States
Patent: 121
Massachusetts, United States
Patent: 108
Washington, United States
Patent: 108
With the analysis among 546 patents, we discovered top 79 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Gammadelta Therapeutics Ltd., Junten Bio Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Gammadelta Therapeutics Ltd.
Tokyo-to, Japan
Patent: 21
Victoria, Australia
Patent: 20
WindMIL Therapeutics, Inc.
New Jersey, United States
Patent: 13
Massachusetts, United States
Patent: 12
LISCure Bioscience Co. Ltd.
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 10
California, United States
Patent: 8
With the analysis among related 5,023 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Iovance Biotherapeutics, Inc., Immatics Biotechnologies GmbH, Bristol Myers Squibb Co. take 8.56% of patent filing during this period.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 193
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 183
New York, United States
Patent: 54
Institut National de la Santé et de la Recherche Médicale
Washington, United States
Patent: 50
The Johns Hopkins University
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 47
Genocea Biosciences, Inc.
Massachusetts, United States
Patent: 41
New Jersey, United States
Patent: 39
Ave Maria Biotechnology LLC
Washington, United States
Patent: 38
With the analysis among related 5,023 patents in last 5 years, we discover 241 new entrants. Ave Maria Biotechnology LLC, Gammadelta Therapeutics Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Ave Maria Biotechnology LLC
Washington, United States
Patent: 38
Gammadelta Therapeutics Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 25
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 25
Massachusetts, United States
Patent: 22
Tokyo-to, Japan
Patent: 21
Centre Hospitalier Universitaire Vaudois
Vaud, Switzerland
Patent: 17
Nanjing Dahu Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 14
With the analysis among 5,403 patents, we discovered top 256 universities and scientific research institutions by total patent application. The Johns Hopkins University, Massachusetts Institute of Technology, The Scripps Research Institute are dominant in this area. They take 10.77% of the total patent filing.
The Johns Hopkins University
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 50
The Scripps Research Institute
California, United States
Patent: 46
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 44
University of Southern California
California, United States
Patent: 42
University of South Florida
Washington University in St. Louis
Missouri, United States
Patent: 38
Connecticut, United States
Patent: 36
Minnesota, United States
Patent: 32
New York, United States
Patent: 31